Alternative excitotoxic hypotheses, Neurology, vol.42, pp.733-738, 1992. ,
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness, Ann Neurol, vol.31, pp.119-130, 1992. ,
Energetics in the pathogenesis of neurodegenerative disorders, Trends Neurosci, vol.7, pp.298-304, 2000. ,
Neurochemical and histologic characterization of the striatal lesions produced by the mitochondrial toxin 3-nitropropionic acid, J Neurosci, vol.13, pp.4181-4192, 1993. ,
Specific caspase pathways are activated in the two stages of cerebral infarction, J Neurosci, vol.21, pp.7127-7134, 2001. ,
The adenosine A1 receptor agonist ADAC exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid of neurotoxicity, J Neurosci, vol.22, pp.9122-9133, 2002. ,
Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in Rat, J Neurochem, vol.70, pp.794-805, 1998. ,
Replicating Huntington's disease in experimental animals, Prog Neurobiol, vol.59, pp.427-458, 1999. ,
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia, Ann Neurol, vol.41, pp.646-653, 1997. ,
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine, J Neurosci, vol.21, pp.5110-5120, 2001. ,
Loss of normal huntingtin function: new developments in Huntington's disease research, Trends Neurosci, vol.24, pp.182-188, 2001. ,
NMDA receptor function in mouse models of Huntington disease, J Neurosci Res, vol.66, pp.525-539, 2001. ,
Caspase and calpain substrates: roles in synaptic plasticity and cell death, J Neurosci Res, vol.58, pp.167-190, 1999. ,
Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid, J Cereb Blood Flow Metab, vol.20, pp.789-799, 2000. ,
Excitotoxic injury of the neostriatum: a model for Huntington's disease, Trends Neurosci, vol.13, pp.286-289, 1990. ,
Calpain inhibitors: a treatment for Alzheimer's disease, J Mol Neurosci, vol.19, pp.135-141, 2002. ,
Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons, J Neurochem, vol.69, pp.1382-1388, 1997. ,
Participation of Par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid, Exp Neurol, vol.165, pp.1-11, 2000. ,
Calpain activation in Huntington's disease, J Neurosci, vol.22, pp.4842-4849, 2002. ,
Activation of the c-Jun-N-terminal kinase/c-Jun module occurs in striatal neurons in response to 3-nitropropionic acid: a comparative in vivo and in vitro analysis, J Neurosci, vol.22, pp.2174-2184, 2002. ,
Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate, J Neurochem, vol.64, pp.430-436, 1995. ,
3-nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms, Neuroscience, vol.84, pp.503-510, 1998. ,
Mitochondrial defect in Huntington's disease caudate nucleus, Ann Neurol, vol.39, pp.385-389, 1996. ,
The influence of huntingtin protein size on nuclear localization and cellular toxicity, J Cell Biol, vol.141, pp.1097-1105, 1998. ,
Huntington's disease, 1991. ,
Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease, Proc Natl Acad Sci, vol.97, pp.2875-2880, 2000. ,
Post-translational modifications of ICA512 a receptor tyrosine phosphatase-like protein of secretory granules, Eur J Neurosci, vol.11, pp.2609-2620, 1999. ,
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, vol.72, pp.971-983, 1993. ,
Evidence for an energy metabolic defect in Huntington's Disease using localized proton spectroscopy, Neurology, vol.43, pp.2689-2693, 1993. ,
1H NMR spectroscopy studies of Huntington's Disease correlation with CAG repeat numbers, Neurology, vol.50, pp.1357-1365, 1998. ,
Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin 3-nitropropionic acid, J Cereb Blood Flow Metab, vol.20, pp.119-129, 2000. ,
Caspase-3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains associate with membranes and undergo calpain-dependent proteolysis, Proc Natl Acad Sci, vol.98, pp.12784-12789, 2001. ,
Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia, Proc Natl Acad Sci, vol.96, pp.5752-5757, 1999. ,
Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease, J Neurosci, vol.21, pp.9112-9123, 2001. ,
Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, vol.405, pp.360-364, 2000. ,
1-Methyl-4-phenylpy ridinium induces autocrine excitotoxicity protease activation and neuronal apoptosis, Mol Pharmacol, vol.54, pp.789-801, 1998. ,
Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock, FASEB, vol.15, pp.171-186, 2001. ,
Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration, J Neurosci, vol.22, pp.4478-4486, 2002. ,
URL : https://hal.archives-ouvertes.fr/cea-02290628
Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia, J Neurosci, vol.18, pp.3659-3668, 1998. ,
Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septohippocampal cultures, J Cereb Blood Flow Metab, vol.21, pp.1281-1294, 2001. ,
Caspases: killer proteases, Trends Biochem Sci, vol.22, pp.299-306, 1997. ,
Astroglial trophic support and neuronal cell death: Influence of cellular energy level on type of cell death influenced by mitochondrial toxin in cultured rat cortical neurons, J Neurochem, vol.75, pp.925-933, 2000. ,
Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionate in rats: implications for neuroprotection studies, Neurosci, vol.97, pp.521-530, 2000. ,
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines, Nat Neurosci, vol.5, pp.731-736, 2002. ,
Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors, Mol Pharmacol, vol.53, pp.974-980, 1998. ,
Recent advances on the pathogenesis of Huntington's disease, Exp Neurol, vol.157, pp.1-18, 1999. ,
A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum, Brain Res Mol Brain Res, vol.80, pp.111-122, 2000. ,
Caspase-8 is required for cell death induced by expanded polyglutamine repeats, Neuron, vol.22, pp.623-633, 1999. ,
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, vol.95, pp.55-66, 1998. ,
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization, Nat Med, vol.5, pp.1194-1198, 1999. ,
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia, Cell Death Differ, vol.5, pp.847-857, 1998. ,
Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum, Exp Neurol, vol.121, pp.57-64, 1993. ,
Lysosomal protease pathways to apoptosis: cleavage of BID, not pro-caspases, is the most likely route, J Biol Chem, vol.276, pp.3149-3157, 2001. ,
Biochemical abnormalities and excitotoxicity in Huntington's disease brain, Ann Neurol, vol.45, pp.25-32, 1999. ,
The calpain cascade. Mucalpain activates m-calpain, J Biol Chem, vol.271, pp.33161-33164, 1996. ,
Calpain and caspase: can you tell the difference?, Trends Neurosci, vol.23, pp.20-26, 2000. ,
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease, J Neurosci, vol.22, pp.7862-7872, 2002. ,
3-nitropropionic acid toxicity in the striatum, J Neurochem, vol.63, pp.1772-1781, 1994. ,
Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade, J Pharmacol Exp Ther, vol.275, pp.1124-1130, 1995. ,
Increased sensitivity to N-methyl-Daspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease, Neuron, vol.33, pp.849-860, 2002. ,